DE60124255T2 - Verwendung von exogenen milchsäurebakterien zur behandlung von durch actinomyces naeslundii hervorgerufenen krankheiten - Google Patents

Verwendung von exogenen milchsäurebakterien zur behandlung von durch actinomyces naeslundii hervorgerufenen krankheiten Download PDF

Info

Publication number
DE60124255T2
DE60124255T2 DE60124255T DE60124255T DE60124255T2 DE 60124255 T2 DE60124255 T2 DE 60124255T2 DE 60124255 T DE60124255 T DE 60124255T DE 60124255 T DE60124255 T DE 60124255T DE 60124255 T2 DE60124255 T2 DE 60124255T2
Authority
DE
Germany
Prior art keywords
cncm
lactic acid
strains
composition
bacterial strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60124255T
Other languages
German (de)
English (en)
Other versions
DE60124255D1 (de
Inventor
c/o Prof. James C. Paulson Elena-Maria 10550N.TorreyPines Road LA Jolla COMELLI
Bernhard Guggenheim
Jean-Richard Neeser
Francesca Stingele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of DE60124255D1 publication Critical patent/DE60124255D1/de
Publication of DE60124255T2 publication Critical patent/DE60124255T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/206—Slime forming bacteria; Exopolysaccharide or thickener producing bacteria, ropy cultures, so-called filant strains
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60124255T 2000-06-02 2001-05-30 Verwendung von exogenen milchsäurebakterien zur behandlung von durch actinomyces naeslundii hervorgerufenen krankheiten Expired - Fee Related DE60124255T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00201948 2000-06-02
EP00201948A EP1159951A1 (en) 2000-06-02 2000-06-02 Use of exogenous lactic bacteria strain against Actinomyces naeslundii-related diseases
PCT/EP2001/006268 WO2001091711A1 (en) 2000-06-02 2001-05-30 Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases

Publications (2)

Publication Number Publication Date
DE60124255D1 DE60124255D1 (de) 2006-12-14
DE60124255T2 true DE60124255T2 (de) 2007-06-06

Family

ID=8171588

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124255T Expired - Fee Related DE60124255T2 (de) 2000-06-02 2001-05-30 Verwendung von exogenen milchsäurebakterien zur behandlung von durch actinomyces naeslundii hervorgerufenen krankheiten

Country Status (25)

Country Link
US (2) US20030170184A1 (enExample)
EP (2) EP1159951A1 (enExample)
JP (1) JP2003534362A (enExample)
KR (1) KR20030031490A (enExample)
CN (1) CN1279890C (enExample)
AR (1) AR028672A1 (enExample)
AT (1) ATE343932T1 (enExample)
AU (2) AU7244901A (enExample)
BR (1) BR0111371A (enExample)
CA (1) CA2410591A1 (enExample)
DE (1) DE60124255T2 (enExample)
ES (1) ES2275697T3 (enExample)
HU (1) HUP0301271A2 (enExample)
IL (1) IL153127A0 (enExample)
IN (1) IN2002CH01972A (enExample)
MX (2) MX243373B (enExample)
MY (1) MY142363A (enExample)
NZ (1) NZ522911A (enExample)
PE (1) PE20011328A1 (enExample)
PH (1) PH12001001365B1 (enExample)
PL (1) PL202576B1 (enExample)
PT (1) PT1296636E (enExample)
UY (1) UY26748A1 (enExample)
WO (1) WO2001091711A1 (enExample)
ZA (1) ZA200210308B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1287745A1 (en) 2001-08-24 2003-03-05 The Procter & Gamble Company Chewable compositions with probiotic agents
US8038990B2 (en) * 2005-06-01 2011-10-18 The Ohio State University Compositions and methods for the prevention and removal of biofilms on inert and biological surfaces
JP2012512171A (ja) * 2008-12-16 2012-05-31 ネステク ソシエテ アノニム 改善された口腔健康のための組成物及び方法
CN111518866A (zh) 2011-03-01 2020-08-11 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
PL3049073T3 (pl) * 2013-09-24 2021-10-25 The Regents Of The University Of Michigan Kompozycje i sposoby destabilizowania, modyfikowania i rozpraszania biofilmów
CN104546941B (zh) * 2014-09-30 2019-01-08 深圳华大基因科技有限公司 内氏放线菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
EP3302090A1 (en) 2015-06-08 2018-04-11 Chr. Hansen A/S Glycerin-based gummy candy and foam candy products with probiotic bacteria
JP7271431B2 (ja) * 2017-02-10 2023-05-11 エボニック オペレーションズ ゲーエムベーハー 少なくとも１種のバイオサーファクタント及びフッ化物を含有するオーラルケア組成物
CN121379862B (zh) * 2025-12-23 2026-04-17 卡士乳业(深圳)有限公司 一种含ct-02菌株的抗感染益生菌剂及其制备方法和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135739A (en) * 1983-02-15 1992-08-04 Kitasato Kenkyusho Non-cariogenic composition and drink
JPS59220191A (ja) 1983-04-07 1984-12-11 Kitasato Inst:The 非う蝕性組成物および飲料
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
CH671879A5 (enExample) 1987-02-26 1989-10-13 Nestle Sa
JPH0421633A (ja) 1990-05-17 1992-01-24 Saikon Medics:Kk 生体下口腔内有用微生物叢の維持管理法および維持管理組成物
FR2672494A1 (fr) 1991-02-13 1992-08-14 Madinier Isabelle Ferments prophylactiques favorisant la prevention de la carie dentaire.
DE4117782C2 (de) 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanokristalline magnetische Eisenoxid-Partikel, Verfahren zu ihrer Herstellung sowie diagnostische und/oder therapeutische Mittel
JPH054927A (ja) 1991-06-28 1993-01-14 Aizo Matsushiro 乳酸菌含有組成物及びその製造方法
ES2124060T5 (es) 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
GB9224598D0 (en) 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
CO4560537A1 (es) 1992-12-28 1998-02-10 Nestle Sa Composicion lactea y procedimiento de preparacion
CH684773A5 (fr) 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
US5368845A (en) 1993-01-07 1994-11-29 Colgate Palmolive Company Oral composition
US5358858A (en) 1994-03-17 1994-10-25 National Science Council Process for preparing phycoerythrin from bangia atropurpurea and porphyra angusta
DE69421921T2 (de) * 1994-08-19 2000-05-11 Societe Des Produits Nestle S.A., Vevey Verzweigtes Polysaccharide, es produzierender Mikroorganismus und Zusammensetzungen welche sie enthalten
EP0776163A4 (en) * 1994-09-09 1999-11-24 Univ Maryland BACTERIOPHAGE-ENCODING ENZYMES FOR THE TREATMENT AND PREVENTION OF DENTAL CARIES AND PERIODONTAL DISEASES
JP3101173B2 (ja) 1995-03-22 2000-10-23 雪印乳業株式会社 フローズンヨーグルトの製造法
PT748591E (pt) 1995-06-16 2002-04-29 Nestle Sa Caseinas micelares fluoradas
DE69529982T2 (de) 1995-08-07 2003-09-04 Societe Des Produits Nestle S.A., Vevey Bakteriozin
JP3356599B2 (ja) 1995-09-22 2002-12-16 雪印乳業株式会社 低酸度型フローズンヨーグルトの製造法
KR19990024297A (ko) * 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
IL140641A (en) * 1998-08-12 2007-07-04 Nestle Sa Incorporation of exogenous lactic bacteria into the oral microflora
DE10034647C1 (de) * 2000-07-14 2002-04-04 3M Espe Ag Verfahren zur Durchführung einer Speichelanalyse

Also Published As

Publication number Publication date
PT1296636E (pt) 2007-02-28
HUP0301271A2 (hu) 2003-08-28
PL360850A1 (en) 2004-09-20
ATE343932T1 (de) 2006-11-15
AU2001272449B2 (en) 2005-10-06
EP1159951A1 (en) 2001-12-05
MXPA02011973A (es) 2003-04-22
IN2002CH01972A (enExample) 2005-02-11
MXPA01001038A (es) 2001-06-01
CN1444469A (zh) 2003-09-24
PL202576B1 (pl) 2009-07-31
CN1279890C (zh) 2006-10-18
UY26748A1 (es) 2001-11-30
US7491386B2 (en) 2009-02-17
MX243373B (es) 2007-01-19
PE20011328A1 (es) 2002-01-23
CA2410591A1 (en) 2001-12-06
US20050074416A1 (en) 2005-04-07
JP2003534362A (ja) 2003-11-18
PH12001001365B1 (en) 2009-02-24
EP1296636A1 (en) 2003-04-02
AU7244901A (en) 2001-12-11
DE60124255D1 (de) 2006-12-14
NZ522911A (en) 2003-08-29
MY142363A (en) 2010-11-30
ES2275697T3 (es) 2007-06-16
KR20030031490A (ko) 2003-04-21
WO2001091711A1 (en) 2001-12-06
BR0111371A (pt) 2003-05-20
IL153127A0 (en) 2003-06-24
ZA200210308B (en) 2004-03-19
EP1296636B1 (en) 2006-11-02
AR028672A1 (es) 2003-05-21
US20030170184A1 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
AU773799B2 (en) Incorporation of exogenous lactic bacteria into the oral microflora
US20060127330A1 (en) Composition for treating and/or preventing periodontal disease
DE69007831T2 (de) Bioaktives Produkt; Zusammensetzungen und Stoffe, die dieses bioaktive Produkt enthalten.
EP1002052A1 (en) Novel lactic acid bacteria
AU2001272449B2 (en) Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases
DE69002024T2 (de) Bioaktive Laktoferrin Derivate.
DE60037343T2 (de) Bifidobakterien mit der fähigkeit diarrhoe zu verhindern
KR102438800B1 (ko) 유산균 발효 노니 추출물을 유효성분으로 하는 구강질환 예방 또는 치료용 조성물
AU2001272449A1 (en) Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases
CN116200307A (zh) 一种猫口腔护理益生菌组合物及其应用
JP2019011268A (ja) 口腔常在菌調整剤を含む口腔用組成物、口腔ケア製品及び食品
WO1987005625A1 (fr) Procede de regulation de biocenoses mixtes, microbiennes et stables
DE2522999A1 (de) Mittel mit antikarieswirkung, dessen herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee